Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.29 USD | +10.26% | -19.38% | -53.43% |
Mar. 18 | Transcript : Biofrontera Inc., Q4 2023 Earnings Call, Mar 18, 2024 | |
Mar. 15 | Biofrontera Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 40.7M | Sales 2025 * | 49.94M | Capitalization | 6.57M |
---|---|---|---|---|---|
Net income 2024 * | -16M | Net income 2025 * | -3M | EV / Sales 2024 * | 0.16 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.13 x |
P/E ratio 2024 * |
-0.4
x | P/E ratio 2025 * |
-2.37
x | Employees | 84 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 70.65% |
Latest transcript on Biofrontera Inc.
1 day | +10.26% | ||
1 week | -19.38% | ||
Current month | -29.89% | ||
1 month | -38.28% | ||
3 months | +88.60% | ||
6 months | -67.67% | ||
Current year | -53.43% |
Managers | Title | Age | Since |
---|---|---|---|
Hermann Lübbert
CEO | Chief Executive Officer | 68 | 15-02-28 |
Fred Leffler
DFI | Director of Finance/CFO | 40 | 22-10-23 |
Erica Gates
DFI | Director of Finance/CFO | - | 19-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Borer
BRD | Director/Board Member | 66 | 21-11-01 |
Hermann Lübbert
CEO | Chief Executive Officer | 68 | 15-02-28 |
Kevin Weber
BRD | Director/Board Member | 66 | 22-03-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 1.29 | +10.26% | 76,635 |
24-05-13 | 1.17 | -7.14% | 177,391 |
24-05-10 | 1.26 | -20.25% | 289,444 |
24-05-09 | 1.58 | +2.60% | 39,366 |
24-05-08 | 1.54 | -3.75% | 35,796 |
Delayed Quote Nasdaq, May 14, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.43% | 6.57M | |
+31.06% | 688B | |
+30.35% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+15.53% | 239B | |
+10.16% | 210B | |
-8.14% | 200B | |
+8.12% | 167B |
- Stock Market
- Equities
- BFRI Stock